DCH INTERNATIONAL A/S financials
DCH INTERNATIONAL A/S
213800HW8TWW9K5AQL18 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €70.5M | €61.6M |
| Gross profit | €24.7M | €25.4M |
| Employee benefits expense | €9.7M | €7.0M |
| Operating profit (EBIT) | €5.5M | €10.7M |
| Finance costs | €2.7M | €3.1M |
| Profit before tax | €2.9M | €7.7M |
| Income tax expense | €489.0K | €1.2M |
| Profit for the year | €2.4M | €6.5M |
| — attributable to owners | €2.4M | €6.5M |
| Total comprehensive income | €2.7M | €9.0M |
| Cash flow statement | ||
| Cash generated from operations | €6.1M | €17.2M |
| Net cash from operating activities | €2.1M | €13.8M |
| Income taxes paid | €1.5M | €674.0K |
| Net cash from investing activities | -€1.3M | -€4.5M |
| Purchase of PP&E (capex) | €5.7M | €1.3M |
| Purchase of intangibles | €44.0K | €0 |
| Net cash from financing activities | €698.0K | -€10.3M |
| Proceeds from borrowings | €6.0M | €212.0K |
| Repayments of borrowings | €5.3M | €10.5M |
| Net change in cash | €1.5M | -€937.0K |
| Balance sheet | ||
| Total assets | €146.5M | €137.0M |
| Non-current assets | €89.0M | €94.9M |
| Right-of-use assets | €1.4M | €1.7M |
| Current assets | €57.5M | €42.1M |
| Inventories | €9.2M | €8.4M |
| Trade & other receivables | €6.6M | €6.2M |
| Cash & equivalents | €8.5M | €7.0M |
| Total equity | €91.8M | €89.1M |
| Non-current liabilities | €13.5M | €19.2M |
| Lease liabilities (non-current) | €762.0K | €467.0K |
| Current liabilities | €41.2M | €28.7M |
| Deferred tax liabilities | €0 | €367.0K |
| Derived metrics | ||
| Free cash flow | -€3.6M | €12.5M |
| Operating margin | 7.8% | 17.4% |
| Net margin | 3.4% | 10.5% |
| Return on equity | 2.6% | 7.3% |
| Cash conversion ratio | 0.87× | 2.13× |
| Capex coverage | 0.37× | 10.55× |
| Other reported items | ||
| Adjustments For Decrease Increase In Biological Assets | -€6.0M | -€1.5M |
| Adjustments For Decrease Increase In Inventories | -€837.0K | €1.5M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€10.2M | -€864.0K |
| Adjustments For Depreciation Expense | €7.7M | €7.7M |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | -€4.0M | €1.4M |
| Adjustments For Increase Decrease In Trade and Other Payables | €5.9M | €1.0M |
| Comprehensive Income Attributable To Owners of Parent | €2.7M | €9.0M |
| Construction In Progress | €3.0M | €915.0K |
| Current Biological Assets | €16.3M | €13.3M |
| Current Prepayments | €586.0K | €827.0K |
| Deferred Tax Assets | €762.0K | €0 |
| Depreciation Expense | €7.6M | €7.7M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€1.0K | -€17.0K |
| Equity and Liabilities | €146.5M | €137.0M |
| Finance Costs Paid Classified As Operating Activities | €2.6M | €2.9M |
| Finance Income | €119.0K | €137.0K |
| Finance Income Received Classified As Operating Activities | €119.0K | €137.0K |
| Gains Losses On Fair Value Adjustment Biological Assets | -€4.0M | €1.4M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | -€23.0K | -€12.0K |
| Income Tax Relating To Changes In Revaluation Surplus of Other Comprehensive Income | €138.0K | €415.0K |
| Increase Decrease Through Sharebased Payment Transactions | €0 | -€22.0K |
| Intangible Assets Other Than Goodwill | €293.0K | €351.0K |
| Issued Capital | €12.8M | €12.8M |
| Land and Buildings | €65.6M | €68.0M |
| Liabilities | €54.8M | €47.9M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €294.0K | €315.0K |
| Noncurrent Biological Assets | €5.6M | €10.5M |
| Noncurrent Deferred Income Including Noncurrent Contract Liabilities | €1.6M | €1.7M |
| Noncurrent Portion of Noncurrent Loans Received | €9.3M | €14.9M |
| Other Comprehensive Income | €288.0K | €2.5M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -€144.0K | -€72.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -€317.0K | €403.0K |
| Other Comprehensive Income Before Tax Gains Losses On Revaluation | €866.0K | €2.6M |
| Other Current Liabilities | €5.2M | €2.1M |
| Other Current Receivables | €16.0M | €6.0M |
| Other Noncurrent Liabilities | €1.8M | €1.8M |
| Proceeds From Disposal of Noncurrent Assets Or Disposal Groups Classified As Held For Sale and Discontinued Operations | €21.0K | €88.0K |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €0 | €2.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €487.0K | €176.0K |
| Purchase of Biological Assets | -€3.9M | €3.4M |
| Reserve of Cash Flow Hedges | €0 | €121.0K |
| Reserve of Exchange Differences On Translation | €851.0K | €1.2M |
| Retained Earnings | €67.0M | €63.8M |
| Revaluation Surplus | €11.1M | €11.3M |
| Revenue and Operating Income | €72.9M | €67.0M |
| Trade and Other Current Payables To Trade Suppliers | €7.2M | €3.7M |
| Undrawn Borrowing Facilities | €4.9M | €6.8M |
Every line item above is a fact tagged in DCH INTERNATIONAL A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.